From: How do naloxone-based interventions work to reduce overdose deaths: a realist review
Full reference | Study design | Programme context | Contribution to synthesis | ||||
---|---|---|---|---|---|---|---|
NBIT-A | NBIT-B | NBIT-C | ST-A | ST-B | |||
Ambrose et al., 20161 | Bivariate and multivariate associations, sensitivity analysis | Harm reduction programme | X | X | Â | Â | Â |
Baca et al., 20072 | Qualitative structured interviews | Harm reduction programme, syringe exchange (low threshold) | Â | Â | Â | Â | X |
Banjo et al., 20143 | Evaluation (mixed methods) | BCCD harm reduction programme | X | X | X | X | X |
Behar et al., 20154 | Survey (repeated measures) | DOPE programme (low threshold), syringe exchange (low threshold) | X | Â | Â | X | Â |
Bennett et al., 20115 | Evaluation (survey, repeated measures) | Harm reduction programme Negative attitudes (police) | X | Â | X | X | X |
Bennett& Holloway, 20126 | Evaluation (survey, repeated measures) | Harm reduction programme | X | Â | Â | Â | Â |
Beswick et al., 20027 | Qualitative structured interviews | Unknown | Â | Â | Â | X | Â |
Bowles et al., 20198 | Qualitative semi structured interviews | Harm reduction programme, syringe exchange (low threshold) | X | X | Â | Â | Â |
Clark & Eustace, 20169 | Evaluation (mixed methods-repeated measures and semi-structured interviews) | Harm reduction programme Negative attitudes (General Practitioner [GP]) | Â | Â | X | Â | Â |
Chronister et al., 201810 | Evaluation (survey repeated measures) | Harm reduction, low threshold health care facility and abstinence-based programmes where low threshold services are embedded | X | X | Â | X | Â |
Das et al., 201711 | Case study | Needle exchange (low threshold) | Â | X | Â | Â | Â |
Dettmer et al., 200112 | Case study | Health care project, mobile drug services (low threshold) | X | Â | Â | X | Â |
Doe-Simkins et al., 200913 | Evaluation (prospective cohort) | Needle exchange (low threshold) | X | X | Â | X | X |
Doe- Simkins et al., 201414 | Retrospective cohort study | Syringe exchange (low threshold) | X | X | Â | X | X |
Dwyer et al., 201515 | Evaluation (survey repeated measures) | Low threshold, detoxification centres, abstinence-based residential drug treatment | X | X | Â | X | Â |
Enteen et al., 201016 | Evaluation (prospective cohort) | DOPE programme (low threshold), syringe exchange (low threshold) opioid substitution clinic, hostels | X | X | Â | Â | X |
Espelt et al., 201717 | Survey (repeated measures) | Needle exchange (low threshold), outreach, supervised injection facilities (harm reduction) | X | Â | Â | X | Â |
EuroNPUD, 201918 | Report (grey literature) | Â Unknown | X | X | Â | X | Â |
Galea et al., 200619 | Pilot (pre-/post-overdose experiences) | Syringe exchange (low threshold) | X | Â | Â | X | Â |
Gaston et al., 200920 | Evaluation (prospective cohort, survey repeated measures) | Abstinent-based programme (inpatient and outpatient) Negative attitudes (police) | Â | Â | X | Â | Â |
George et al., 201021 | Case study | Community drug team | X | Â | Â | X | Â |
Gilbert et al., 201822 | Randomised controlled trial | SKOOP training programme (harm reduction) | X | Â | Â | X | Â |
Green et al., 200823 | Between groups (trained vs untrained, questionnaire) | Needle exchange (low threshold) and abstinence-based drug treatment centre | X | Â | Â | Â | Â |
Green et al., 201424 | Case study | Prison naloxone programme | X | X | Â | X | Â |
Farrugia et al., 201925 | Case study | Peer run drug consumer organisation | Â | X | Â | X | Â |
Khatiwoda et al., 201826 | Mixed methods (survey and open-ended questions) | Harm reduction | X | Â | Â | X | Â |
Lankenau et al., 201327 | Evaluation qualitative-closed and open-ended questions) | Syringe exchange (low threshold), community health care programmes Negative attitudes (police) | X | X | X | X | X |
Leece et al., 201328 | Evaluation (cohort) | Syringe exchange (low threshold) | X | Â | Â | X | Â |
Leece et al., 201629 | Evaluation (mixed methods-survey and one-to-one interviews) | Syringe exchange (low threshold) | X | X | Â | X | Â |
Madah-Amiri, et al., 201730 | Evaluation (prospective cohort, overdose prevention behaviours) | Syringe exchange, supervised injection site (low threshold) | X | X | Â | X | Â |
Maldah-Amiri, et al., 201931 | Prospective cohort (survey, repeated measures) | Syringe exchange (low threshold) | X | Â | Â | X | Â |
Maldjian, et al., 201632 | Prospective cohort (survey, repeated measures) | Syringe exchange (low threshold) | X | Â | Â | X | Â |
Maxwell (2006)33 | Report (prospective cohort, post training knowledge) | Chicago Recovery Alliance programme (harm reduction) | X | Â | Â | Â | Â |
McAuley et al., 201034 | Evaluation (prospective cohort, post training knowledge) | Lanarkshire naloxone project (low threshold) | X | Â | Â | Â | Â |
Nelson et al., 201635 | Evaluation (mixed methods, survey repeated measures, one-to-one interviews) | Low threshold | X | X | Â | X | X |
NIHD (n.d.)36 | Report (post training actions taken in an overdose) | Harm reduction | X | Â | Â | X | Â |
Olsen et al., 201537 | Evaluation (mixed methods-survey repeated measures, semi-structured interviews) | Harm reduction | X | Â | Â | X | X |
PHA, 201638 | Report (post training) | Low threshold services | X | Â | Â | X | X |
Parmar et al., 201739 | Randomised control pilot trial | N-Alive programme (low threshold) | Â | Â | Â | X | Â |
Piper et al., 200840 | Evaluation (survey) | SKOOP programme (harm reduction) | X | Â | Â | Â | Â |
Rowe et al., 201541 | Survey | Harm reduction | X | Â | Â | X | Â |
Ruane, 201942 | News article (describing barriers to naloxone programmes) | Harm reduction Negative attitudes (GP) | Â | Â | X | Â | Â |
Seal et al., 200543 | Pilot study (prospective cohort, survey) | Harm reduction Negative attitudes (Police) | X | Â | X | X | X |
Sherman et al., 200844 | Qualitative one-to-one semi-structured interviews | Harm reduction centre, syringe exchange (low threshold) Negative attitudes (ambulatory staff) | X | Â | X | X | Â |
Sherman et al., 200945 | Qualitative one-to-one interviews | Staying Alive programme (low threshold), needle exchange (low threshold) | X | X | Â | X | Â |
Shorter & Bingham, 201646 | Evaluation (qualitative semi structured interviews) | Negative attitudes (police) | Â | Â | X | Â | Â |
Siegler et al., 201747 | Prospective cohort (questionnaire) | Syringe exchange programme (low threshold) | X | Â | Â | X | Â |
Strang et al., 200848 | Prospect cohort (pre-/post-training questionnaire) | Abstinence-based inpatient and outpatient drug treatment programme | X | Â | Â | Â | Â |
Tobin et al., 200949 | Evaluation (prospective cohort, pre-/post-training) | Staying Alive programme (harm reduction), syringe exchange (low threshold) | X | Â | Â | X | X |
Traynor, 201950 | News article (reports of actions taken in an overdose) | Harm reduction and community outreach programmes | X | Â | Â | X | Â |
Wagner et al., 201051 | Evaluation (questionnaire) | Harm reduction | X | X | Â | X | Â |
Wagner et al., 201452 | Qualitative one-to-one interviews | Syringe exchange within a community health care, Homeless Health Care, Los Angeles centre for harm Reduction, Skid Row Negative attitudes (police) | X | Â | X | X | Â |
Walley et al., 201353 | Interrupted time series analysis | Harm reduction, Chicago Recovery Alliance programme | X | Â | X | Â | Â |
Worthington et al., 200654 | Qualitative focus group interviews | Lower east side harm reduction centre Negative attitudes (police) | X | Â | X | Â | Â |
Yokell et al., 201155 | Evaluation (post training) | Mixed: syringe exchange, AIDS outreach, homeless shelters, abstinence-based substance abuse treatment programmes | Â | Â | Â | X | Â |